Litcius/Paper detail

Direct Oral Anticoagulants Compared With Dalteparin for Treatment of Cancer-Associated Thrombosis: A Living, Interactive Systematic Review and Network Meta-analysis

Irbaz Bin Riaz, Harry E Fuentes, Syed Arsalan Ahmed Naqvi, Huan He, Qurat-ul-Ain Riaz Sipra, Alfonso Tafur, Leslie Padranos, Waldemar E. Wysokiński, Ariela L. Marshall, Per Olav Vandvik, Víctor M. Montori, Alan H. Bryce, Hongfang Liu, Robert G. Badgett, M. Hassan Murad, Robert D. McBane

2021Mayo Clinic Proceedings29 citationsDOI

Topics & Concepts

MedicineEdoxabanRivaroxabanApixabanRandomized controlled trialMeta-analysisOdds ratioDabigatranThrombosisInternal medicineIntensive care medicineWarfarinAtrial fibrillationVenous Thromboembolism Diagnosis and ManagementHepatocellular Carcinoma Treatment and PrognosisHeparin-Induced Thrombocytopenia and Thrombosis
Direct Oral Anticoagulants Compared With Dalteparin for Treatment of Cancer-Associated Thrombosis: A Living, Interactive Systematic Review and Network Meta-analysis | Litcius